대한신장학회

Skip Navigation: Skip to contents

KOR
ENG
전체메뉴보기

간행물 검색

현재 페이지 경로

HOME
간행물
간행물 검색

논문분류	춘계학술대회 초록집
제목	Receiving Red Yeast Rice Prescriptions (LipoCol Forte) Increased the Risk of End-Stage Renal Disease or Not? a Retrospective Cohort Study and a Case-Control Study
저자	Chien-Chang Liao
출판정보	2025; 2025(1):
키워드	red yeast rice, end-stage renal disease, retrospective cohort study
초록	The potential association between red yeast rice (RYR) use and the risk of end-stage renal disease (ESRD) remains unclear. This study aimed to evaluate the risk of ESRD in patients received RYR compared to those who were not. A retrospective cohort study was conducted using Taiwan’s national insurance claims data from 2010 to 2014, including 67,876 RYR users and 90,836 lovastatin users, with follow-up until 2019. ESRD incidence was compared between cohorts using multiple Cox regressions and adjusted hazard ratios (HRs) and 95% confidence intervals (CIs). During follow-up, ESRD incidence was 0.9 per 1,000 person-years in RYR users compared to 3.7 per 1,000 person-years in non-users (HR 0.33, 95% CI 0.30-0.37). The association between RYR and ESRD risk was existed in various subgroups. A dose-dependent reduction in ESRD risk was observed with increasing RYR prescriptions. Sensitivity analysis, excluding ESRD cases within the initial six months, confirmed a persistent association between RYR use and reduced ESRD risk (HR 0.61, 95% CI 0.27-0.57). RYR use was associated with a lower risk of ESRD, however, medication adherence warrant cautious interpretation. Further randomized controlled trials are needed to clarify RYR’s role in slowing kidney disease progression.
원문(PDF)	PDF 원문보기

목록

위로가기